
    
      Given the promising clinical results of previous trials of probiotics for IBS symptoms, the
      objective of this clinical trial is to evaluate the safety and effectiveness of a proprietary
      probiotic product, Lactobacillus acidophilus CL1285®, Lactobacillus casei LBC80R® and
      Lactobacillus rhamnosus CLR2® on symptoms of IBS in otherwise healthy adults.
    
  